EZH2 and breast cancer: Consistent with our findings in the tissue microarray analysis that the presence of EZH2 in osteosarcoma is linked to higher metastatic migration, similar observations have also been reported in pancreatic cancer, prostate cancer, oral tongue squamous cell carcinoma, and breast cancer [32–34].